Latest Edition,2026 ICD-10-CM Diagnosis Code R76.0

The cyclic citrullinated peptide (CCP) antibody test is a crucial diagnostic tool, particularly in the realm of rheumatology. This article delves into the significance of CCP antibodies, their role in diagnosing conditions like rheumatoid arthritis (RA), and how they are represented in the ICD-10 coding system. We will explore the ICD-10 Diagnosis Codes relevant to these findings, including specific codes such as 2026 ICD-10-CM Diagnosis Code M05.9, 2026 ICD-10-CM Diagnosis Code R76.0, and 2026 ICD-10-CM Diagnosis Code M05.A.

What are Cyclic Citrullinated Peptide Antibodies?

Cyclic citrullinated peptide (CCP) antibodies, often referred to as anti-CCP antibodies, are a type of autoantibody. Autoantibodies are proteins produced by the immune system that mistakenly attack the body's own tissues. In the case of anti-CCP antibodies, they target citrullinated proteins and peptides. Citrullination is a natural post-translational modification of proteins, but in certain autoimmune conditions, the body begins to produce antibodies against these modified proteins.

The CCP antibody test specifically detects IgG antibodies against a set of cyclic citrullinated peptides. These antibodies are considered highly specific serologic tests for aiding in the workup of suspected rheumatoid arthritis (RA) or undifferentiated inflammatory arthritides. The presence of CCP antibodies has been shown to be highly specific for RA and often appears early in the disease process, making it a valuable diagnostic marker when the diagnosis is most difficult.

The Role of CCP Antibodies in Diagnosing Rheumatoid Arthritis

Rheumatoid arthritis is a chronic inflammatory disorder that can affect joints and other parts of the body. A definitive diagnosis of RA often involves a combination of clinical examination, patient history, and laboratory tests. The CCP antibody test is a key component in this diagnostic process.

A positive result for cyclic citrullinated peptide (CCP) antibodies in the blood, when considered in conjunction with other laboratory and clinical findings, is an aid in the diagnosis of rheumatoid arthritis. It is often performed along with or after a rheumatoid factor (RF) test, as both can indicate RA. However, the anti-CCP test is generally considered more specific for RA than the rheumatoid factor.

The CCP Ab is a useful new diagnostic marker for rheumatoid arthritis. Elevated anti-cyclic citrullinated peptide (anti-CCP) antibody levels are characteristically elevated in rheumatoid arthritis, although they can sometimes be elevated in other conditions. This makes it a powerful tool for clinicians to help diagnose or rule out rheumatoid arthritis.

ICD-10 Coding for CCP Antibody Findings

The International Classification of Diseases, Tenth Revision (ICD-10) is a standardized system used for coding medical diagnoses and procedures. When a CCP antibody test is performed and yields specific results, particular ICD-10 Diagnosis Codes are assigned. This coding is vital for tracking individuals, billing purposes, and research.

One significant code is ICD-10 code R76.81, which represents "Abnormal rheumatoid factor and anti-citrullinated protein antibody without rheumatoid arthritis." This code is used when these antibodies are detected but the patient does not yet meet the full criteria for rheumatoid arthritis, potentially indicating an increased risk. Another relevant code is ICD-10-CM R76.0, which signifies "Raised antibody titer."

For cases where rheumatoid arthritis is diagnosed, specific codes are used. For instance, 2026 ICD-10-CM Diagnosis Code M05.9 represents "Rheumatoid arthritis with rheumatoid factor, unspecified." Furthermore, 2026 ICD-10-CM Diagnosis Code M05.A indicates "Abnormal rheumatoid factor and anti-citrullinated protein antibody with rheumatoid arthritis." These codes are part of the broader category of rheumatology ICD 10 codes used by healthcare professionals.

The presence of CCP antibodies can also be coded under various ICD-10 Diagnosis Codes that reflect seropositivity. For example, seropositive rheumatoid arthritis ICD-10 codes are used to document this specific aspect of the disease. Researchers and healthcare providers utilize these codes to identify patients with specific serological profiles, such as seropositive erosive rheumatoid arthritis ICD 10.

Cyclic Citrullinated Peptide Antibody Test Details

The CCP antibody test requires a blood sample. The test measures cyclic citrullinated peptide (CCP) antibodies in the blood, screening for both IgG and IgA antibodies associated with rheumatoid arthritis. A positive anti-CCP result typically indicates a person has RA, particularly if they also test positive for rheumatoid factor.

The interpretation of the test results depends on established reference ranges. For example, at 20 U/mL and